Trial Profile
Study of effects on the retina and the choroid of intravitreal ranibizmab injection in patients with macular edema due to central retinal vein occlusion.
Status:
Active, no longer recruiting
Phase of Trial:
Phase II
Latest Information Update: 14 Nov 2018
Price :
$35
*
At a glance
- Drugs Ranibizumab (Primary)
- Indications Retinal oedema
- Focus Therapeutic Use
- 15 Nov 2017 New trial record